SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jacques Chitte who wrote (3144)3/28/1998 9:29:00 PM
From: Ploni  Read Replies (1) of 7041
 
On what revenue are these earnings based, if Vasomax is gonna be slow to market? Zona reports earnings this Wednesday. Estimates are $.44. That's four and a half million dollars on the plus side. From what?

Here's the deal:
(a) Start a company
(b) Sell stock
(c) Use some of the proceeds to pay yourself, plus you'll still own plenty of stock which you can sell from time-to-time
(d) Put the rest of the proceeds from the stock sale in the bank
(e) The bank pays you interest income
(f) No you can report income. Revenues are not necessary.

This trick has worked for many companies, such as YHOO.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News